Paws Pharmaceuticals Revenue

Pharmaceutical Manufacturing • • 1-10 Employees

Paws Pharmaceuticals revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Paws Pharmaceuticals

Milan Malhi

Chief Executive Officer

Company overview

Headquarters	XX
Website	pawspharma.com
NAICS	3254
Employees	1-10
Socials

Paws Pharmaceuticals Email Formats

Paws Pharmaceuticals uses 1 email format. The most common is {first name} (e.g., john@pawspharma.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@pawspharma.com	100%

About Paws Pharmaceuticals

PAWS Pharma is a company that aims to change pet medicine and make it better. They are searching worldwide to find the latest technology and research, developing cutting-edge animal medicines and medical diagnostics. They offer board and train programs, innovative solutions for pets suffering from osteoarthritis, and a groundbreaking patented technology called hylin. They also provide support and resources for interested and curious vets.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Paws Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Paws Pharmaceuticals has never raised funding before.

Frequently asked questions

Paws Pharmaceuticals is located in XX.

Paws Pharmaceuticals generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Paws Pharmaceuticals has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Paws Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Paws Pharmaceuticals

Milan Malhi

Chief Executive Officer

4.8

40,000 users